About Switzer Lifescience Private Limited
Data last updated:
Switzer Lifescience Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2009PTC056360. Its GSTIN is 24AAMCS8688R1Z1 (Gujarat).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Jiteenkumar Shantilal Vadgama and Jayesh Rasiklal Patni.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 705 Siddhivinayak Tower B/H Dcp Office Off S G High – Way Makarba, Ahmedabad, Gujarat, India – 380051.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.93 Cr, a decline of 35% compared to the previous year. For the same year it recorded a net profit of ₹1.76 Lakh (net margin 0.4%) and EBITDA of ₹2.43 Lakh (EBITDA margin 0.5%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 1% over five years.
The company is associated with 1 brand: Switzer Lifescience.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website switzerlifescience.com.
Company details
Contact details
Switzer Lifescience Private Limited's registered office is in Ahmedabad, Gujarat. Its website is switzerlifescience.com. Its e-mail address is in the company report.
- Email
- Website
- Registered AddressC – 705 Siddhivinayak Tower B/H Dcp Office Off S G High – Way Makarba, Ahmedabad, Gujarat, India – 380051
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Switzer Lifescience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Switzer Lifescience operates one associated brand: Switzer Lifescience. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and distribution of drugs and veterinary products in India. | switzerlifescience.com |
Business activity
The main business activity of Switzer Lifescience is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Switzer Lifescience Private Limited, buy the company report.
Financials of Switzer Lifescience Private Limited
FY 2025 filings availableSwitzer Lifescience Private Limited reported revenue of ₹4.93 Cr (down 35% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 35% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 1%. EBITDA fell 52% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.43 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.76 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.5% | ||||
| Net Profit Margin | 0.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Switzer Lifescience Private Limited, buy the company report.
Board of directors of Switzer Lifescience Private Limited
Switzer Lifescience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jiteenkumar Shantilal Vadgama | Director | 16 Mar 2009 | 17 Years 7 Months | Current |
| Jayesh Rasiklal Patni | Director | 16 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Switzer Lifescience Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Uttranchal Pharmaceuticals Private Limited | ₹4.94 Cr (FY 2025) | 2.0% | New Delhi, Delhi, India | |||
| Lewis Bioserch Pharma Private Limited | ₹4.94 Cr (FY 2024) | 19.0% | Chandigarh, India | |||
| Cataliq Laboratories Private Limited | ₹4.94 Cr (FY 2024) | -12.0% | Ahmedabad, Gujarat, India | |||
| Karlin Pharmaceuticals & Exports Private Limited | ₹4.93 Cr (FY 2025) | 12.0% | Chennai, Tamil Nadu, India | |||
| Switzer Lifescience Private Limitedthis company | ₹4.93 Cr (FY 2025) | ₹1.76 Lakh | 0.4% | -35.0% | Ahmedabad, Gujarat, India | |
| Reliv Healthcare Private Limited | ₹4.93 Cr (FY 2022) | -18.0% | Mumbai, Maharashtra, India | |||
| Variety Pharmaceuticals Pvt Ltd | ₹4.92 Cr (FY 2025) | -11.0% | Palakkad, Kerala, India | |||
| La-Pharma(Gujarat) Private Limited | ₹4.91 Cr (FY 2025) | -6.0% | Ahmedabad, Gujarat, India |
To see the full peer comparison of Switzer Lifescience Private Limited, buy the company report.
Auditor
Switzer Lifescience Private Limited is audited by S N BHAVSAR & CO for the financial year 2019.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S N BHAVSAR & CO | FY 2019 | 114045W |
Shareholding
The shareholding of Switzer Lifescience Private Limited is on record for 3 financial years, the latest being FY 2019, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2019 | FY 2017 | FY 2016 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Switzer Lifescience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Switzer Lifescience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Switzer Lifescience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Switzer Lifescience has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAMCS8688R1Z1 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Switzer Lifescience Private Limited, buy the company report.
Recent activity
Switzer Lifescience Private Limited has 2 board changes on record since 2009: 2 appointments. The latest: Jayesh Rasiklal Patni was appointed as Director on 16 Mar 2009.
Frequently asked questions
Switzer Lifescience is an active private limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 March 2009 (17+ years old) and is registered under CIN U24230GJ2009PTC056360.
Switzer Lifescience has 2 current directors:
- Jiteenkumar Shantilal Vadgama - Director
- Jayesh Rasiklal Patni - Director
The latest financial statements of Switzer Lifescience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Switzer Lifescience is 24AAMCS8688R1Z1, registered in Gujarat.
The CIN (Corporate Identification Number) of Switzer Lifescience is U24230GJ2009PTC056360. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Switzer Lifescience was incorporated on 16 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Switzer Lifescience by revenue are Uttranchal Pharmaceuticals Private Limited, Lewis Bioserch Pharma Private Limited, Cataliq Laboratories Private Limited, Karlin Pharmaceuticals & Exports Private Limited, Reliv Healthcare Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jayesh Rasiklal Patni was appointed as Director on 16 Mar 2009. Jiteenkumar Shantilal Vadgama was appointed as Director on 16 Mar 2009.
Switzer Lifescience can be reached through the website switzerlifescience.com. Its registered office is in Ahmedabad, Gujarat, India.
The registered office of Switzer Lifescience is at C – 705 Siddhivinayak Tower BH Dcp Office Off S G High – Way Makarba, Ahmedabad, Gujarat, India – 380051.
Switzer Lifescience operates in the pharma industry, in the drug formulation and development segment.